The neuropharmacology of nightmares

Sleep and Sleep Disorders: A Neuropsychopharmacological Approach

Volumn , Issue , 2006, Pages 241-250

  Pagel, J F ^a  

^a Rocky Mountain Sleep Disorders Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902402628     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-27682-3_27     Document Type: Chapter

References (88)

1. Fisher C, Byrne J, Edwards A et al. A psychophysiological study of nightmares. J Am Psychoanal Assoc 1970; 18:747-782.
2. Nielsen TA, Zadra A. Dreaming disorders. In: Kryger MH, Roth T, Dement WC, eds. Principles and praaice of sleep medicine. 3rd ed. Philadelphia, PA: WB Saunders Co., 2000:753-772.
3. Solms M. Dreaming and REM sleep are controlled by different brain functions. In: Pace-Schott EF, Solms M, Blagrove M, et al, eds. Sleep and Dreaming: Scientific Advances and Reconsiderations. Cambridge: Cambridge University Press, 2003:51-58.
4. Hobson JA, Steriade M. The neuronal basis of behavioral state control: Internal regulatory systems of the brain. In: Bloom F, Mountcastle V, eds. Handbook of Psychology. Washington DC: American Physiological Society, 1986:IV(14):701-823.
5. Kandle ER. The brain and behavior. In: Kan del ER, Schwartz JH, Jessell TM, eds. Principles of Neural Science. 4th ed. New York: McGraw Hill, 2000:5-18.
6. Schwartz JH. Neurotransmitters. In: Kandel ER, Schwartz JH, Jessell TM, eds. Principles of Neural Science. 4th ed. New York: McGraw Hill, 2000:280-297.
7. Rye DB. Contributions of the pedunculopontine region to normal and altered REM sleep. Sleep 1997; 20(9):757-788.
8. Pace-Schott EF. Postscript: Recent findings on the neurobiology of sleep and dreaming. In: Pace-Schott EF, Solms M, Blagrove M, et al, eds. Sleep and Dreaming: Scientific Advances and Reconsiderations. Cambridge: Cambridge University Press, 2003:335-350.
9. Hobson JA, Pace-Schott EF, Stickgold R. Dream science 2000: A response to commentaries on dreaming and the brain. In: Pace-Schott EF, Solms M, Blagrove M, et al, eds. Sleep and Dreaming: Scientific Advances and Reconsiderations. Cambridge: Cambridge University Press, 2003:231-246.
10. Pagel JF, Helfter P. Drug induced nightmares - An etiology based review. Hum Psychopharmacol Clin Exp 2003; 18:59-67.
11. Perry E, Perry R. Acetylcholine and hallucinations: Disease-related compared to drug-induced alterations in human consciousness. Brain and Cognition 1995; 28:240-258.
12. Hobson JA. The chemistry of conscious states. Boston: Little, Brown and Company, 1994.
13. Solms M. The neuropsychology of dreams - A clinicoanatomical study. Mahwah, New Jersey: Lawrence Erlbaum Associates, Publishers, 1997.
14. Francis A. (Chair - Task Force on DSM-IV) DSM-IV - Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC: American Psychiatric Association, 1994.
15. Pagel JF, (Chairman) Blagrove M, Levin R et al. Defining dreaming - A paradigm for comparing interdisciplinary studies of dream. The bulletin of the American Academy of Sleep Medicine, 1999; 6(4):34.
16. Pagel JF, Blagrove M, Levin R et al. Definions of dream - A paradigm for comparing field descriptive specific studies of dream. Dreaming 2001; 11 (4): 195-202.
17. Krakow B, Neidhardt J. Conquering bad dreams and nightmares: A guide to understanding, interpretation and cure. New York: Berkley Books, 1992.
18. Kuiken D, Sikora S. The impact of dreams on waking thoughts and feelings. In: Moffitt A, Kramer M, Hoffman R, eds. The Functions of Dreaming. Albany, NY: State University of New York Press, 1993:419-476.
19. Zadra A, Donderi DC. Prevalence of nightmares and bad dreams and their relation to psychological well-being, Jornal of Abnormal Psychology 2000; 109:210-219.
20. Thorpy M, ed. American sleep disorders association, the international classification of sleep disorders. Revised: Diagnostic and coding manuel. Rochester, MN: American Sleep Disorders Association, 1997.
21. Pagel JF. Nightmares and disorders of dreaming. American Family Physician Apr 2000; 61(7):2037-2042.
22. Bixler EO et al. Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry 1979; 136:1257-1262.
23. Klink M, Quan SF. Prevalence of reported sleep disturbances in a general adult population and their relationship to obstructive airway diseases. Chest 1987; 91:540-546.
24. Moffitt A, Kramer M, Hoffman R, eds. The functions of dreaming. Albany, NY: State University of New York Press, 1993.
25. Terr LC. Nightmares in Children. In: Guilleminault C, ed. Sleep and its Disorders in Children. New York: Raven, 1987.
26. Wood JM, Bootzin RR. The prevalence of nightmares and their independence from anxiety. J Abnorm Psychol 1990; 99:64-68.
27. Fawzi MC et al. The validity of posttraumatic stress disorder among Vietnamese refiigees. Journal of Tramna and Stress 1997; 10:101-108.
28. Grillon C et al. Baseline starde amplitude and prepulse inhibition in Vietnam veterans with posttraumatic stress disorder. Psychiatry Research 1996; 64:169-178.
29. Yehuda R, McFarlane AC. Conflict between current knowledge about posttraumatic stress disorder and its original conceptual basis. American Journal of Psychiatry 1995; 152:1705-1713.
30. Schenck CH, Mahowald MW. REM sleep parasomnias. Neurology Clinics 1996; 14:697-720.
31. Ekbiad S, Roth G. Diagnosing posttraumatic stress disorder in multicultural patients in a Stockholm psychiatric clinic. Journal of Nervous and Mental Disease 1997; 185:102-107.
32. Ross RJ et al. Sleep disturbance as the hallmark of posttraumatic stress disorder. American Journal of Psychiatry 1989; 146:697-707.
33. Pagel JF. Modeling drug actions on electrophysiological effects produced by EEG modulated potentials. Human Psychopharmachology 1993; 8(3):211-216.
34. Pagel JR Pharmachologic alteration of sleep and dreams - A clinical framework for using the electrophysiological and sleep stage effeas of psychoactive medications. Human Psychopharmachology 1996; 11(3):217-224.
35. Hobson JA. The chemistry of conscious states. Boston: Litde, Brown and Company, 1994; 258.
36. Foulkes D. Dreaming: A cognitive-psychological analysis. Hillsdale, New Jersey: Lawrence Erlbaum Associates, 1985.
37. Cohen DB. Sleep and dreaming: Origins. Nature and Function. New York: Pergamon, 1979.
38. Baekeland F, Lasky R. The morning recall of rapid eye movement period reports given earlier in the night. Journal of Nervous and Mental Disease 1968; 147:570-579.
39. Nielsen TA. A review of mentation in REM and NREM sleep: "Covert" REM sleep as a possible reconciliation of two opposing models. In: Pace-Schott EF, Solms M, Blagrove M, Harnard S, eds. Sleep and Dreaming: Scietific Advances and Reconsiderations. Cambridge: Cambridge University Press, 2003:59-74.
40. Lavie P, Hefez A, Halperin G et al. Long term effeas of traumatic war-related events on sleep. Am J Psychiatry 136(2):175-178.
41. Kramer M, Kinney L. Sleep patterns in trauma viaims with disturbed dreaming. Psychiar J Univ Ottawa 1988; 139(1):12-16.
42. Sakai K, Crochet S, Onoe H. Pontine structures and mechanisms involved in the generation of paradoxical (REM) sleep. Archives Italiennes de Biologic 2001; 139:93-107.
43. Siegel JM. Brainstem mechanisms generating REM sleep. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. 3rd ed. Philadelphia, PA: WB Saunders Co., 2000:112-133.
44. Gottesmann C. Neurophysiological support of consciousness during waking and sleep. Progress in Neurobiology 1999; 59:469-508.
45. Mallick BN, Kaur S, Saxena RN. Interactions between cholinergic and gabanergic neurotransmitters in and around the locus coeruleus for the induction and maintence of rabid eye movement sleep in rats. Neuroscience 2001; 104(2):467-485.
46. Standaert D, Saper C, Rye D et al. Colocalization of atriopeptin-like immunoreactivity with choline acetyltransferase and substance-P like immunoreactivity in the pedunculopontine and laterodorsal tegmental necuh of die rat. Brain Res 1986; 382:163-8.
47. Vincent SR, Satoh K, Armstrong DM et al. Neuropeptides and NADPH-diaphorase activity in ascending cholinergic rectular system of the rat. Neuroscience 1986; 17:167-82.
48. Vincent S, Kimura H. Histochemical mappin of nitric oxide synthase in the rat brain. Neuroscience 1992; 46:755-84.
49. Austin M, Rice P, Mann J et al. Localization of corticotrophinreleasing hormone in the human locus coeruleus and pedunculopontine tegmental nucleus: An immunocytochemical an in situ hybridization study. Neuroscience 1995; 64:713-27.
50. Lavoie B, Parent A. Pedunculopontine nucleus in squirrel monkey: Distribution of cholinergic and monoaminergic neurons in the mesopontine tegmentum with evidence for the presence of glutamate in cholinergic neurons. J Comp Neurol 1994; 334:190-209.
51. Buchsbaum MS, Hazlett EA, Wu J et al. Positron emission tomography with deoxyglucose-F18 imaging in sleep. Neuropsychopharmacology 2001; 25:S50-6.
52. Nofeinger EA, Nichols TE, Meltzer CC et al. Changes in forebrain function from waking to REM sleep in depression: Preliminary analysis of [18F] FDG PET studies. Psychiatry Research: Neuroimaging 1999; 91:59-78.
53. Hong CCH, Gillin JC, Dow BC et al. Localized and lateralized cerebral glucose metabolism associated with eye movements during REM sleep and wakefulness: A positron emission tomography (PET) study. Sleep 1995; 18:570-80.
54. Igawa M, Atsumi Y, Takahashi K et al. Activation of visual cortex in REM sleep measured by 24-channel NIRS imaging. Psychiatry and Clinical Neuroscience 2001; 55:187-8.
55. Kaplan-Solms K, Solms M. Clinical studies in neuro-psychoanalysis. Introduction to a Depth Neuropsychology. London: Karnac Books, 2000.
56. Thompson D, Pierce D. Drug induced nightmares. The annals of pharmacotherapy 1999; 33:93-96.
57. Naranjo CA et al. A method for estimating the probability of adverse drug interaaions. Clinical Pharmacology and Therapeutics 1981; 30:239-245.
58. McCarley R. REM sleep and depression: Common neurobiological control mechanisms, American Journal of Psychiatry 1982; 139(5):565-570.
59. Jouvet M. The paradox of sleep: The story of dreaming. MIT Press, 1999.
60. Baghdoyan FiA, Monaco A, Rodrigo-Angulo M et al. Microinjection of neostigmine into the pontine reaicular formation of cats enhances desynchronized sleep signs. Journal of Pharmacology and Experimental Therapy 1984; 231:173-80.
61. Chase MH, Morales FR. Control of motorneurons during sleep. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. 3rd ed. Philadelphia, PA: WB Saunders Co., 2000:155-168.
62. Hobson JA, Pace-Schott EF, Stickgold R. Dreaming and the brain: Toward a cognitive neuroscience of conscious states. In: Pace-Schott EF, Solms M, Blagrove M, Harnard S, eds. Sleep and Dreaming: Scientific Advances and Reconsiderations. Cambridge: Cambridge University Press, 2003:1-50.
63. Kosten TR, Mason JW, Ciller EL. Sustained urinary norepinephrine and epinephrine elevation in posttraumatic stress disorder. Psychoneuroendocrinology 1987; 12:13-20.
64. Southwick SM, Krystal JH, Morgan CA et al. Abnormal Noradrenergic function in posttraumatic stress disorder. Arch Gen Psychiatry 1993; 50:266-274.
65. Kolb LC, Burris BC, Griffiths S. Propranolol and clonidine in the treatment of post traumatic stress disorders of war. In: Van der Kolk BA, ed. Posttraumatic Stress Disorder: Psychological and Biological Sequelae. Washington DC: American Psychiatric Press Inc., 1984:98-105.
66. Dimsdale J, Newton R. Cognitive effeas of Beta-blockers. Journal of Psychosomatic Research 1991; 36(3):229-236.
67. Brismar K, Motgensen L, Wetterberg L. Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs. Acta Med Scand 1987; 221(2):155-158.
68. Gursky J, Krahn L. The effects of antidepressants on sleep: A review, Harvard. Review of Psychiatry 2000; 8(6):298-306.
69. Coupland NJ, Bell CJ, Potokar JP. Serotonin reuptake inhibitor withdrawal. Journal of Clinical Psychopharmacology 1996; 16(5):356-362.
70. Pace-Schott E et al. Effects of serotonin reuptake inhibitors (SSRI) on dreaming in normal subjeas. Sleep 1999; 22(Sup 1):H278D.
71. Lepkifker E et al. Nightmares related to fluoxetine treatment. Clinical Neuropharmachology 1995; 18(1):90-94.
72. Pace-Schott E et al. Enhancement of subjeaive intensity of dream features in normal subjeas by the SSRI's paroxaine and fluvoxamine. Sleep 2000; 23(Sup. 2):A173.
73. Stacy M. Managing late complications of Parkinsons disease. Medical Clinics of North America 1999; 83(2):469-481.
74. Xi MC, Morales FR, Chase MH. Evidence that wakefulness and REM sleep are controlled by a GABAergic pontine mechanism. Journal of Neurophysiology 1999; 82:2015-2019.
75. Mallick BN, Kaur S, Saxena. Interaaions between cholinergic and GABAnergic neurotransmitters in and around the locus coeruleus for the induction and maintainence of rapid eye movement sleep. Neuroscience 2001; 104:467-485.
76. Oxorn D et al. The effects of midazolam on propofol-induced anesthesia: Propofol dose requirements, mood profiles, and perioperative dreams. Anesth Analg 1997; 85:553-9.
77. Steriade M. Brain electrical activity and sensory processing during waking and sleeping states. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. 3rd ed. Philadelphia, PA: WB Saunders Co., 2000: 93-111.
78. Ansoms A et al. Zopiclone or lometazepam in the treatment of insomnia and the effect on behavior and mood during the post-alcoholism withdrawal period. Current Therapy and Research 1991; 49:54-64.
79. Van Moffaert M et al. Comparison of zopiclone and flunitrazepam in the treatment of insomnia in depressed patients. Current Therapy and Research 1990; 48:140-153.
80. Marsh S et al. Dreaming and anesthesia: Total i.v. Anaesthesia with propofol versus balanced volitile anaeshthesia with enflurane, European Journal of Anaesthesiology 1992; 9:331-333.
81. Krissel J et al. Thiopentone, thiopentone/ketamine, and ketamine for induction of anesthesia in caesarean section. European Journal of Anaesthesiology 1994; 11:115-122.
82. Knill RL, Moote CA, Skinner MI et al. Anesthesia with abdominal surgery leads to intense. REM sleep during the first postoperative week, Anesthesiology 1990; 73(1):52-61.
83. Hobson JA. Dreaming as Delerium. MIT Press, 1999.
84. Krueger JM, Fang J. Host defense, in principles and practice of sleep medicine. In: Kryger M, Roth T, Dement W, eds. Philadelphia, WB: Saunders Co., 2000:3:255-265.
85. Krueger JM, Kubillis S, Shoham S et al. Enhancement of slow wave sleep by endotoxin and libid A. American Journal of Physiology 1986; 251:R591-R597.
86. Jaife SE. Sleep and infectious disease, in principles and practice of sleep medicine. In: Kryger M, Roth T, Dement W, eds. Philadelphia, WB: Saunders Co., 2000:3:1093-1102.
87. McEvoy GK, ed. Cardiac Drugs. AHFS Drug Information. Belthesda, Maryland: American Society of Health Systems Pharmacists, Inc., 2002:24:04.
88. Pagel JR Nondreamers. Sleep Medicine 2003; 4:235-241.